Navigation

Arthritis of the hip (end stage) - hip replacement (total) and resurfacing arthroplasty (Rev TA2, TA44) [ID540]

Total hip replacement and resurfacing arthroplasty for the treatment of pain or disability resulting from end stage arthritis of the hip (Review of technology appraisal guidance 2 and 44)

Status: History
Expected date of issue: February 2014
Process: MTA
Topic area:
 

NICE project team

Executive Lead: Carole Longson
Technical Lead: Mary Hughes
Communications manager: Tonya Gillis
Project manager:

Jeremy Powell

Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 01 February 2013
1st appraisal committee meeting: 18 September 2013
2nd appraisal committee meeting: 20 November 2013
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Amplitude (not participating)
  • B Braun
  • Biomet
  • Corin
  • DePuy-Synthes (Johnson & Johnson)
  • Exactech (not participating)
  • Implantcast (not participating)
  • Implants international (not participating)
  • Joimtmedica (not participating)
  • JRI
  • Lima WG healthcare (not participating)
  • MathysMedacta (not participating)
  • Orthodynamics (not participating)
  • Peter Brehm (not participating)
  • SERF (not participating)
  • Smith & Nephew
  • Stanmore Implants Worldwide (not participating)
  • Stryker
  • Surgicraft (not participating)
  • Symbios (not participating)
  • Waldemar Link (not participating)
  • Wright Medical
  • Zimmer

Patient/carer groups

  • Arthritis Care

Professional groups

  • Association for Perioperative Practice
  • British Hip Society
  • British Orthopaedic Association
  • Chartered Society of Physiotherapy
  • NHS Blood and Transplant
  • Primary Care Rheumatology Society
  • Royal College of Nursing
  • Royal College of Physicians

Others

  • Department of Health
  • Welsh Assembly Government

General

  • Association of British Healthcare Industries (ABHI)
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Healthcare Improvement Scotland
  • Medicines and Healthcare products Regulatory Agency
  • NHS Supply Chain

Comparator manufacturers

  • None
  • Relevant research groups
  • Orthopaedic Research UK

Assessment Group

  • Warwick Evidence
  • National Institute for Health Research Health Technology Assessment Programme

Associated guideline groups

  • Tbc

Associated public health groups

  • Tbc

Top


 

Project history

Date Notes
24 February 2014 Guidance published TA304
1 August 2013 The consultation on the Assessment Report and the Appraisal Committee meetings were rescheduled. This was because more information needed to be collected before the Assessment Report was sent out for consultation.
17 January 2013 At the Consultee information Meeting (CIM) held for this MTA on 11 December, it became clear that in order to allow the aims of the review to be fully met, some elements of the scope need to be clarified. The amended scope has been posted on this page and sent to consultees.
Top


 

Key documents

This page was last updated: 24 February 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.